Skip to main content

Home/ Medicine & Healthcare/ Contents contributed and discussions participated by avivajazz jazzaviva

Contents contributed and discussions participated by avivajazz jazzaviva

avivajazz  jazzaviva

COURAGE Quality-of-Life Analysis: Slim Early Gains With PCI Soon Disappear. (QoL) anal... - 0 views

  •  
    Percutaneous coronary intervention (PCI) can often be deferred in patients with stable coronary artery disease (CAD) and significant coronary lesions without adding risk while optimal medical therapy (OMT) is given a chance to work, and it can be consider
avivajazz  jazzaviva

Abbott Laboratories: Bioabsorbable Drug-Eluting Coronary Stent: March 24, 2007 - 0 views

  •  
    Abbott Announces Positive Six-Month Results from the World's First Clinical Trial of A Fully Bioabsorbable Drug-Eluting Coronary Stent\nAbbott's Bioabsorbable Stent Technology Holds Promise as Future-Generation Treatment Option for Physicians Treating Pati
avivajazz  jazzaviva

MEGA: Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese - 0 views

  •  
    Rader also believes that the MEGA trial raises important questions about just how widespread the use of statin therapy should be in primary prevention...reignite discussion on over-the-counter low-dose statins.
avivajazz  jazzaviva

Wiley InterScience :: Cardiovascular Drug Reviews - 0 views

  •  
    Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG-CoA Reductase Inhibitor
avivajazz  jazzaviva

ATryn New Drug Application - 0 views

  •  
    ATryn (antithrombin alfa) Treatment for Antithrombin III Deficiency - BLA Submitted for ATryn\nGTC Biotherapeutics Completes BLA Submission For ATryn
« First ‹ Previous 321 - 340 of 788 Next › Last »
Showing 20 items per page